The current monopoly of the pharmaceutical industry by corporate giants is costing lives, but individuals and group initiatives are challenging the system, campaigning for widespread use of generic drugs and affordable price tags.
The National Health Service announced last week it wouldn't provide the lifesaving HIV prevention drug, PrEP, to Brits in need. Campaigners are understandably angry.
